Zimmer restructures Americas leadership team
The company promoted three executives and eliminated a fourth position as part of changes intended to support its ongoing commercial transformation.
Uncategorized
Health Catalyst appoints new CEO
Health Catalyst has cycled through three CEOs in eight months. The data analytics company is betting its newest chief can navigate an AI pivot and revenue headwinds.
Half of U.S. hospitals lack maternity wards as Medicaid cuts loom: report
Nearly half of U.S. hospitals are now without obstetric services, according to a new report, and closures could worsen as Medicaid cuts threaten hospital finances.
Half of U.S. hospitals lack maternity wards as Medicaid cuts loom: report Read More »
Drugmakers cherry pick launch regions as MFN creates ‘policy environment like an earthquake’
With multiple drug pricing initiatives like Most Favored Nation now in force, drugmakers have to reinvent their commercial strategies to stay ahead of the fast-moving policy environment, according to a new report from Numerof & Associates.
Biohaven takes another hit as FDA pauses enrollment in pivotal trials for embattled epilepsy drug
The enrollment pause comes after BHV-7000 failed to show efficacy in a midstage depression trial late last year. The news is another regulatory hit for Biohaven after the FDA declined to approve its spinocerebellar ataxia treatment in November 2025.
Tyra shares slip as bladder cancer responses fall short of investor expectations
Despite falling short of analyst expectations, Tyra Biosciences is taking its cancer drug to registrational development for non-muscle invasive bladder cancer.
Tyra shares slip as bladder cancer responses fall short of investor expectations Read More »
Encoded raises $275M series F for Dravet syndrome gene therapy
Encoded Therapeutics’ lead asset ETX101 is a gene therapy being tested for Dravet syndrome. Phase 1/2 data showed substantial reductions in seizures.
Encoded raises $275M series F for Dravet syndrome gene therapy Read More »
The supply chain fault lines of modern pharma
In this episode of Denatured, sponsored by SK Pharmteco, Jennifer Smith-Parker speaks to Arvind Singh, vice president and global head of supply chain. In this episode, we explore how CDMOs are reshaping supply‑chain strategy for a new generation of complex modalities.
Método para capturar nanoplásticos del agua y convertirlos en materiales descontaminantes de metales pesados
Un estudio demuestra que un gramo de unas nuevas y revolucionarias nanoestructuras es capaz de atrapar hasta 10 gramos de nanoplásticos PET. Los nanoplásticos, fragmentos de plástico que por su minúsculo tamaño pueden ser absorbidos fácilmente por tejidos vi …
El modo en que los gusanos C. elegans perciben el mundo no es como se creía
Habitualmente se utiliza al Caenorhabditis elegans, un gusano de un milímetro de longitud, como animal modelo para estudiar la mecanosensación, es decir, la capacidad de los animales de detectar fuerzas mecánicas (como el tacto, la presión o el estiramiento) y convertirla …
El modo en que los gusanos C. elegans perciben el mundo no es como se creía Read More »